FDA taking look at cardiac stent

Nov. 14, 2005 at 7:00 PM

WASHINGTON, Nov. 14 (UPI) -- The Food and Drug Administration is examining a surgical stent after learning that a Michigan hospital stopped using the device for two weeks.

The William Beaumont Hospital in Royal Oak suspended use of Boston Scientific's Taxus stent after two patients were injured, the Wall Street Journal reported. Stents are used to prop open clogged arteries, and with the Taxus stents the wires used to insert them resisted removal.

The hospital has since resumed using the stent with no problems reported. Boston Scientific provided retraining for doctors in the use of the medical device.

However, cardiologists at Beaumont say they were shocked to learn Boston Scientific had told the FDA the problem had been resolved.

Related UPI Stories
Latest Headlines
Trending Stories
Ted Cruz campaign pulls ad featuring softcore porn actress
Lonely horse forms close bond with rescue dog
Ruby Rose, Gigi Hadid react to Kanye West's lyric about Taylor Swift
Kristen Wiig impersonates Peyton Manning on 'The Tonight Show'
NYC police officer found guilty of manslaughter in Brooklyn stairway shooting